Who invested in 27-8 Therapeutics?
27-8 Therapeutics's investors include MPM Capital, Longwood Fund, Vertex, Novartis Venture Fund/ JJDC and Astellas.
United States · Series A startup
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$65Mraised across 1 round since 2018, from 1 source
27-8 Therapeutics's investors include MPM Capital, Longwood Fund, Vertex, Novartis Venture Fund/ JJDC and Astellas.
27-8 Therapeutics has raised $65M across 1 round since 2018.
27-8 Therapeutics's most recent round was a Series A of $65M in Sept 2018.
Its most recent round, $65M in Sept 2018, is also its largest on record.
27-8 Therapeutics's first round on record, in Sept 2018, was backed by MPM Capital, Longwood Fund and Vertex and 2 others.
27-8 Therapeutics's latest named round is a Series A, in Sept 2018.
27-8 Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.